Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › fluticasone

fluticasone

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of fluticasone

20 trials tracked of fluticasone: 12 in phase 3 or 4 and 2 with published results. The most-cited published study has 21 citations.

20Trials tracked
12Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 5 Phase 3 7 Phase 2 3 Other / NA 5
  1. Phase 3 A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Completed · 21 cited
  2. Phase 3 ACTIV-6: COVID-19 Study of Repurposed Medications Completed · 5 cited
  3. Phase 4 Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD Completed
  4. Phase 4 Study Of Allergic Rhinitis In Patients Who Also Have Asthma Completed
  5. Phase 4 The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial Completed
  6. Phase 4 MethaCholine Bronchoprovocation Study (MeCIS) Completed
Show 14 more trials
  1. Phase 4 Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms Completed
  2. Phase 3 Fluticasone Nasal Spray Patient Preference Study Completed
  3. Phase 3 ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone) Completed
  4. Phase 3 Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101) Completed
  5. Phase 3 A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512) Completed
  6. Phase 3 Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma Completed
  7. Phase 2 Topical Steroid Treatment for Eosinophilic Esophagitis Completed
  8. Phase 2 A Phase IIA FF/VI Study to Measure FeNO in Asthmatic Patients. Completed
  9. Phase 2 To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma Completed
  10. N/A Interactive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the Airway Completed
  11. N/A Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone Completed
  12. N/A Effect of an Inhaled Glucocorticosteroid (ICS) on Endothelial Dysfunction in Cigarette Smokers Completed
  13. N/A The Effect of Salmeterol on Eosinophil (EOS) Function Completed
  14. N/A Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment Completed

Showing the 20 most-cited and recently-updated of 20 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.